The stocks of Cepheid, Bruker BioSciences, and Qiagen all gained more than 10 percent for the five-day trading period ended Tuesday.
Cepheid led all gainers in the BCW Index for the week with a 12.6 percent rise in its shares. The firm is due to report its third-quarter results on Nov. 1.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.